Compare FNB & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FNB | GRFS |
|---|---|---|
| Founded | 1864 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.5B |
| IPO Year | 2001 | N/A |
| Metric | FNB | GRFS |
|---|---|---|
| Price | $17.77 | $8.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $19.70 | $10.15 |
| AVG Volume (30 Days) | ★ 7.5M | 588.1K |
| Earning Date | 04-16-2026 | 07-28-2022 |
| Dividend Yield | ★ 2.97% | 1.76% |
| EPS Growth | ★ 22.83 | N/A |
| EPS | ★ 1.56 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.12 | $4.49 |
| Revenue Next Year | $8.35 | $6.42 |
| P/E Ratio | ★ $11.20 | $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.88 | $6.90 |
| 52 Week High | $19.14 | $11.14 |
| Indicator | FNB | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 57.01 | 45.65 |
| Support Level | $17.38 | $7.52 |
| Resistance Level | $18.09 | $8.88 |
| Average True Range (ATR) | 0.40 | 0.19 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 45.83 | 21.97 |
F N B Corp provides a full range of financial services, principally to consumers, corporations, governments, and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management, and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.